Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06586788 · ClinicalTrials.gov registry record · NA
Validation of Indiana's Early Evaluation Hub System
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
NCT06586788 is a NA study that has completed, run by Indiana University. The registered enrollment target is 154 participants.
The verdict
NCT06586788, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
Study Summary
The investigators' objective is to test an innovative method of autism diagnosis that integrates clinical evaluation and assessment of biobehavioral markers in a large high-risk community-referral sample of children in the primary care setting.
Interventions
- DIAGNOSTIC_TEST Eyelink Portable Duo
- DIAGNOSTIC_TEST Integrated PCP Diagnosis and Eye-tracking Biomarker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2019-06-07 |
| Est. Completion | 2022-09-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06586788
The ClinicalTrials.gov registry entry for NCT06586788 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Eyelink Portable Duo is the first listed.
NCT06586788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06586788 about?
NCT06586788 is a clinical study titled "Validation of Indiana's Early Evaluation Hub System". The investigators' objective is to test an innovative method of autism diagnosis that integrates clinical evaluation and assessment of biobehavioral markers in a large high-risk community-referral sample of children in the primary care setting.
What is the current status of trial NCT06586788?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2019-06-07. Estimated completion is 2022-09-23.
What interventions are being tested in trial NCT06586788?
The interventions under investigation include: Eyelink Portable Duo (DIAGNOSTIC_TEST), Integrated PCP Diagnosis and Eye-tracking Biomarker (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06586788?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.